Ishita Drugs & Industries Ltd Share Price

Pharmaceuticals

BSE: 524400 Small Cap ISIN: INE806D01016

As on 18 November 2025 at 23:54 IST

Stock Not Traded in BSE

Over 1 Month

1.94%

Over 6 Months

-2.36%

Over 1 Year

1.10%

Over 3 Years

21.98%

Ishita Drugs & Industries Ltd Summary

Close ₹74.59

Open ₹72.89

High ₹74.87

Low ₹72.88

Volume 898

Net Turnover (in Cr) ₹0.0066

52Wk High ₹99.64

52Wk Low ₹62.35

52Wk High / Low

62.35

99.64

Ishita Drugs & Industries Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹22.30

EPS (TTM) 3.25

Book Value (BV) 37.58

Div. Yield -

P/E (TTM) 22.95

Price/Book Value 1.99

Delivery % 89.98 %

Face Value 10

Key Ratios

PE Ratio 27.08

PB Ratio 2.18

EV to Sales 1.50

PEG Ratio 1.69

ROA 5.92

ROE 8.40

Debt-Equity 0.19

Net Profit Margin 5.80

Operating Profit Margin 8.87

Ishita Drugs & Industries Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	15.33	15.47	12.27	14.20	14.26
Total Expenses	14.18	14.48	11.49	13.15	13.21
Profit Before Tax	1.16	0.99	0.78	1.04	1.05
Profit After Tax	0.87	0.75	0.58	0.80	0.83
Operating Profit After Depreciation	1.23	1.08	0.83	1.07	1.09

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.88	0.80	0.89	0.88	1
Total Non Current Assets	1.31	1.15	1.23	1.21	1.27
Total Current Assets	14.98	9.66	10.18	10.05	7.99
Total Assets	16.30	10.81	11.41	11.25	9.26
Total Shareholder's Fund	10.79	9.92	9.17	8.60	7.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-3.64	2.12	-2.90	3.08	-0.67
Net Cash Used In Investing Activities	-0.67	0.13	0.59	-0.93	2.45
Net Cash Used In Financing Activities	4.33	-0.87	1.05	-	-0.24

No data available

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	3.07	5.40	4.56	4.13	3.27
Total Expenses	2.88	5.05	4.27	3.83	3.03
Profit Before Tax	0.23	0.39	0.38	0.32	0.26
Profit After Tax	0.14	0.30	0.29	0.24	0.19
Operating Profit after Depreciation	0.26	0.44	0.45	0.37	0.29

Ishita Drugs & Industries Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 73.36

S2 72.12

S3 71.37

Pivot 74.11

R1 75.35

R2 76.10

R3 77.34

Moving Average

20 SMA 72.75

50 SMA 75.54

100 SMA 76.44

200 SMA 77.57

Ishita Drugs & Industries Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

Pursuant to the provisions of Regulation 34 of the SEBI (LODR) Regulations 2015 we are enclosing herewith Annual Report for the financial year 2020-21 along with the Notice of 28th Annual General Meeting (AGM) of the Company to be held on 30th September 2021. This is to inform you that the company has fixed Thursday, September 23, 2021 as the cut-off date to determine the entitlement of voting rights of members for e-voting in the ensuing Annual General Meeting Scheduled to be held on Thursday, September 30, 2021. The e-voting period will commence from Monday, September 27, 2021 (10.00 a.m. IST) and ends on Wednesday, September 29, 2021 (5.00p.m IST) (both days inclusive). (As Per BSE Announcement Dated on 31.08.2021) This is to inform you that 28th Annual General Meeting (AGM) of the members of the Company was held on Thursday 30th September 2021 at 11.30 a.m. at The Cascade Pam Inn Regency Hotel Nr. HP Petrol Pump Village Vasana Iyava Taluka Sanand Sanand Viramgam Highway Gujarat 382170. (As Per BSE Announcement Dated on 9/30/2021 3:21:28 AM) Disclosures of E-Voting Results and Scrutinizers Report for 28th Annual General Meeting of the Company held on 30th September 2021 (As Per BSE Announcement Dated on 10/2/2021 7:20:55 AM)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Pursuant to the provisions of Regulation 34 of the SEBI (LODR) Regulations, 2015 we are enclosing herewith Annual Report for the financial year 2021-22 along with the Notice of 29th Annual General Meeting (AGM) of the Company to be held on 30th September, 2022. This is to inform you that the 29th Annual General Meeting of the Company will be held on Friday, 30th September, 2022 at 11.30 a.m. at 'Manthan', Hotel Krsna Lila, Nr. Rexroth Bosch, Village Iyava, Taluka Sanand, Sanand Viramgam Highway, Gujarat 382170 and the share transfer books of the Company will remain closed from 24th September, 2022 to 30th September, 2022 (both days inclusive) for the purpose of 29th Annual General Meeting of the Company This to inform you that the 29th Annual General Meeting (AGM) of the Company will be held on Friday, 30th September, 2022 and the e-voting period for AGM commences on Tuesday, September 27, 2022 (10.00 a.m. IST) and ends on Thursday, September 29, 2022 (5.00 p.m. IST) (both days inclusive). This is to inform you that the Company has fixed Friday, September 23, 2022 as the cut-off date to determine the entitlement of voting rights of members for e-voting in the ensuing Annual General Meeting Scheduled to be held on Friday, September 30, 2022. The e-voting period will commence from Tuesday, September 27, 2022 (10.00 a.m. IST) and ends on Thursday, September 29, 2022 (5.00 p.m. IST) (both days inclusive). (As Per BSE Announcement Dated on 31/08/2022) This is to inform you that 29th Annual General Meeting (AGM) of the members of the Company was held on Friday, 30th September, 2022 at 11.30 a.m. (As Per BSE Announcement dated on 30.09.2022) Pursuant to regulation 30 of the SEBI (LODR) Regulation, 2015, we hereby inform you that the shareholders of the Company, have, in their 29th Annual General Meeting held on 30th September, 2022 approved the following: 1. Increase in the Authorised Share Capital of the Company to Rs. 6,00,00,000/- (Rupees Six Crore Only) divided into 60,00,000/- (Sixty lakhs) equity shares of Rs. 10/- (Rupees Ten Only) each and the consequential changes in clause V of the Memorandum of Association of the Company. 2. Adoption of revised Articles of Association to align with the provisions and regulations contained in the Companies Act, 2013 including the Rules framed thereunder. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 27 Sep 2023

We wish to inform you that the Register of Members and share transfer book of the Company will remain closed from 21st September, 2023 to 27th September, 2023(both days inclusive) for the purpose of Annual general Meeting of the Company. Pursuant to the provisions of Regulation 34 of the SEBI (LODR) Regulations, 2015 we are enclosing herewith Annual Report for the Financial Year 2022-23 along with the Notice of 30th Annual General Meeting (AGM) of the Company to be held on 27th September, 2023. This is to inform you that the 30th Annual General Meeting(AGM) of the Company will be held on Wednesday, 27th September, 2023 and the E voting period for AGM commence on Sunday, 24th September, 2023 (10:00 IST) and ends on Tuesday, 26th September, 2023(5:00 IST) (both days inclusive). (As Per BSE Announcement Dated on 29/08/2023) Outcome of Annual General Meeting of Ishita Drugs and Industries limited held on 27th September, 2023. (As Per BSE Announcement Dated on 27.09.2023) Disclosure of Voting Results and Scrutinizer''s Report for 30th Annual General Meeting of the Company held on 27th September, 2023. (As Per BSE Announcement Dated on 29/09/2023) Revised - Proceedings of the 30th Annual General Meeting held on 27th September, 2023. (As Per BSE Announcement Dated on 08/04/2024)

AGM Date: 30 Sep 2024

AGM 30/09/2024 We wish to inform you that Register of Members and share transfer book of the Company remain closed from 24th September, 2024 to 30th September, 2024 (both days inclusive) for the purpose of Annual General Meeting of the Company. The E voting period for ensuing 31st AGM which is to be held on 30th September, 2024 will commence from Friday, 27th September, 2024 (09:00 a.m. IST) and ends on Sunday, 29th September, 2024 (05:00 p.m. IST) (both days inclusive) and the cut off date for the same is 23rd September, 2024. (As Per BSE Announcement dated on 24.08.2024) Proceedings of 31st Annual General Meeting of the Company held on Monday, 30th September, 2024 at 11:30 A.M. and Concluded on 12:45 P.M. (As Per Bse Announcement Dated on 30.09.2024) Disclosure of Voting Results and Scrutinizer''s Report for 31st Annual General Meeting of the Company held on 30th September, 2024. Pursuant to the provisions of section 139,142 and other applicable provisions, if any, of the Companies Act, 2013, and rules framed there under, as amended from time to time, the Company hereby appoints M/s. Jaymin Shah & Associates, Chartered Accountants (FRN: 129406W) as the Statutory Auditor of the Company for the Financial Year 2024-25. Read less.. 1. Approval of regularization of the Appointment of Ms. Dhwani Solanki (DIN: 10299290) as a Independent Director (Non -Executive) of the company for a first term of 5 Consecutive yeras. 2. Approval of Re-appointment of Mr. Jagdishprasad Agrawal (DIN: 01031687) as a Managing Director of the Company. 3. Approval of Re-appointment of M/s. Jaymin Shah & Associates, Chartered Accountants (FRN: 129406W) as the Statutory Auditor of the Company for the financial year 2024-25. Read less.. (As Per BSE Announcement Dated on 02.10.2024)

AGM Date: 29 Sep 2025

AGM 29/09/2025 We wish to inform you that Register of members and share transfer book of the Company remain closed from 23rd September, 2025 to 29th September, 2025 (both days Inclusive) for the purpose of Annual General Meeting of the Company. Proceedings of 32nd Annual General Meeting of the Company held on Monday, 29th September, 2025 at 11:30 A.M. and concluded on 12:40 P.M. (As Per BSE Announcement Dated on: 29/09/2025) Disclosure of Voting Results and Scrutinizer''s Report for 32nd Annual General Meeting of the Company held on Monday, 29th September, 2025 (As Per BSE Announcement Dated on:01.10.2025)

Ishita Drugs & Industries Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Ishita Drugs & Industries Ltd Top Mutal Funds Invested

No data available

Ishita Drugs & Industries Ltd News

Ishita Drugs & Industries to declare Quarterly Results

On 11 November 2025

06 Nov 2025, 01:53 pm

Ishita Drugs & Industries to hold AGM

On 29 September 2025

03 Sep 2025, 03:54 pm

Ishita Drugs & Industries to convene board meeting

On 12 August 2025

07 Aug 2025, 02:04 pm

Ishita Drugs & Industries to hold board meeting

On 13 June 2025

11 Jun 2025, 09:43 am

Ishita Drugs & Industries to table results

On 30 May 2025

24 May 2025, 05:36 pm

Ishita Drugs & Industries Ltd Stock Analysis

Annual revenue for Ishita Drugs & Industries Ltd decreased by 0.87% to ₹15.33 crore in FY 2025 from ₹15.47 crore in FY 2024.
Annual Net Profit for Ishita Drugs & Industries Ltd increased by 15.98% to ₹0.87 crore in FY 2025 from ₹0.75 crore in FY 2024.
Promoter Shareholding in Ishita Drugs & Industries Ltd increased by 0.08% in the most recent quarter, from 49.92% in June 2025 to 49.96% in September 2025.
Ishita Drugs & Industries Ltd delivered a 1-year return of 1.10% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Ishita Drugs & Industries Ltd share price moved down by 100.00% from its previous close of INR ₹74.59. The latest Ishita Drugs & Industries Ltd share price is INR ₹0.
Ishita Drugs & Industries Ltd share price today has been at a low of 72.88 and a high of 74.87. Over the past 52 weeks, the Ishita Drugs & Industries Ltd share price has seen a low of 62.35 and a high of 99.64.